ID
10515
Description
Adverse Event Form NCT00058149 A Phase III, Randomized Study of Gemcitabine (Fixed-Dose Rate Infusion) and Oxaliplatin (NSC 266046) Versus Gemcitabine (Fixed-Dose Rate Infusion) Versus Gemcitabine (30-Minute Infusion) in Pancreatic Carcinoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A6276505-5438-3D62-E034-0003BA0B1A09
Link
Keywords
Versions (3)
- 9/19/12 9/19/12 -
- 6/1/15 6/1/15 -
- 6/3/15 6/3/15 -
Uploaded on
June 3, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0 Legacy
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Adverse Event Form NCT00058149
No Instruction available.
- StudyEvent: Adverse Event Form
Description
Adverse event
Description
CTCAdverseEventTerm
Data type
text
Description
CTCAdverseEventGrade
Data type
text
Description
CTCAdverseEventAttributionCode
Data type
text
Description
CTCAdverseEventTerm,Other
Data type
text
Description
Comments
Description
Comments
Data type
text
Description
InvestigatorSignature
Data type
text
Alias
- NCI Thesaurus Property
- C25678
- UMLS 2011AA Property
- C1519316
- NCI Thesaurus ObjectClass
- C17089
- UMLS 2011AA ObjectClass
- C0035173
Description
InvestigatorSignatureDate
Data type
date
Description
Ccrr Module For Adverse Event Form
Similar models
No Instruction available.
- StudyEvent: Adverse Event Form
C1511726 (UMLS 2011AA ObjectClass)
C25416 (NCI Thesaurus Property)
C1691222 (UMLS 2011AA Property)
C1519316 (UMLS 2011AA Property)
C17089 (NCI Thesaurus ObjectClass)
C0035173 (UMLS 2011AA ObjectClass)